EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Intragenic recombination and a chimeric outer membrane protein in the relapsing fever agent Borrelia hermsii


, : Intragenic recombination and a chimeric outer membrane protein in the relapsing fever agent Borrelia hermsii. Journal of Bacteriology 175(9): 2516-2522

The spirochete Borrelia hermsii, a relapsing fever agent, evades the host's immune response through multiphasic antigenic variation. Antigen switching results from sequential expression of genes for serotype-specific outer membrane proteins known as variable major proteins (Vmp's); of the 25 serotypes that have been identified for the HS1 strain, serotypes 7 and 21 have been studied in greatest detail. In the present study, an atypical variant was predominant in the relapse from a serotype 21 infection in mice; relapse cells were bound by monoclonal antibodies specific for Vmp21 as well as antibodies specific for Vmp7. In Western blots (immunoblots), the variant had a single Vmp that was reactive with monoclonal antibodies representing both serotypes. The gene encoding this Vmp, vmp7/21, was cloned and characterized by restriction mapping and sequence analysis to determine the likely recombination event. Whereas the 5' end of vmp7/21 was identical to that of vmp21, its 3' end and flanking sequences were identical to the 3' end of vmp7. Unlike other vmp genes examined thus far, the vmp7/21 gene existed only in an expressed form; a silent, storage form of the gene was not detected. We conclude that the vmp7/21 gene was created by an intragenic recombination between the formerly expressed vmp21 gene and a silent vmp7 gene. This finding suggests that the lack of cross-reactivity between variants, which is usually observed, results from immunoselection against variants possessing chimeric Vmp's rather than from a switching mechanism that excludes partial gene replacements.


Accession: 002416151

PMID: 7683020

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Kitten T.; Barerra A.V., 1991: Molecular analysis of borrelia hermsii variant with a chimeric outer membrane protein. Abstracts of the General Meeting of the American Society for Microbiology 91: 67

Barbour, A.G.; Carter, C.J.; Sohaskey, C.D., 2000: Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsii. Borrelia hermsii, an agent of relapsing fever, undergoes antigenic variation of serotype-specifying membrane proteins during mammalian infections. When B. hermsii is cultivated in broth medium, one serotype, 33, eventually predominates in the popu...

Zhong, J.; Barbour, A.G., 2004: Cross-species hybridization of a Borrelia burgdorferi DNA array reveals infection- and culture-associated genes of the unsequenced genome of the relapsing fever agent Borrelia hermsii. The known genome sequence of Borrelia burgdorferi, an agent of Lyme borreliosis, was used to study the genetic content and gene expression in B. hermsii, another spirochete pathogen and a cause of relapsing fever. Cross-species hybridization of a...

Carter C.; Freitag C.; Davidson B., 1991: Characterization of a non switching variant of the relapsing fever agent borrelia hermsii. Abstracts of the General Meeting of the American Society for Microbiology 91: 67

Ferdows, M.S.; Serwer, P.; Griess, G.A.; Norris, S.J.; Barbour, A.G., 1996: Conversion of a linear to a circular plasmid in the relapsing fever agent Borrelia hermsii. Spirochetes of the genus Borrelia have genomes composed of both linear and circular replicons. We characterized the genomic organization of B. burgdorferi, B. hermsii, B. turicatae, and B. anserina with pulsed-field gel electrophoresis. All four s...

Barbour, A.G., 2016: Chromosome and Plasmids of the Tick-Borne Relapsing Fever Agent Borrelia hermsii. The zoonotic pathogen Borrelia hermsii bears its multiple paralogous genes for variable antigens on several linear plasmids. Application of combined long-read and short-read next-generation sequencing provided complete sequences for antigen-encodi...

Kitten, T.; Barbour, A.G., 1992: The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Borrelia hermsii, a spirochete which causes relapsing fever in humans and other mammals, eludes the immune response by antigenic variation of the "Vmp" proteins. This occurs by replacement of an expressed vmp gene with a copy of a silent...

Barbour, A.G.; Burman, N.; Carter, C.J.; Kitten, T.; Bergström, S., 1991: Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Borrelia hermsii, an agent of relapsing fever, avoids the host's immune response by means of multiphasia antigenic variation. Serotype specificity is determined by variable antigens called the Vmp lipoproteins. Through recombination between l...

Alugupalli, K.R.; Barnard, M.R.; Schwan, T.G.; Coburn, J.; Michelson, A.D.; Leong, J.M., 1998: Integrin binding and platelet activation by Borrelia hermsii, an agent of tick-borne relapsing fever. Abstracts of the General Meeting of the American Society for Microbiology 98: 108

Barbour, A.G.; Bundoc, V., 2001: In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. The antigenic variation of the relapsing fever agent B. hermsii is associated with changes in the expression of the VIp and Vsp outer membrane lipoproteins. To investigate whether these serotype-defining proteins are the target of a neutralizing a...